Search
Crescent Biopharma Ord Shs
CBIOAdd to Watchlist
14.470USD
-0.550-3.66%
Close 07-31 16:00（ET）Quotes delayed by 15 min
537.47MMarket Cap
LossP/E TTM
CBIO Financials
See Crescent Biopharma Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Crescent Biopharma Ord Shs Earnings Date
Latest Release
Jul 30, 2026
EPS / Forecast
-0.81/-0.80
Revenue / Forecast
0.00/312.50K
Period
FY2025 Earnings
Revenue(YoY)
10.84M
--
EPS(YoY)
-14.97
74.51%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its total revenue reached 10.84M, with a year-on-year change of 10.84M.
What are the current assets of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its current assets were 236.66M, with a year-on-year change of 2033.67.
What are the total assets of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its total assets of Crescent Biopharma Ord Shs were 240.29M, with a year-on-year change of 2066.47.
What are the total liabilities of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its total liabilities of Crescent Biopharma Ord Shs were 37.28M, with a year-on-year change of 545.24.
What is the total equity of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its total equity of Crescent Biopharma Ord Shs was 203.01M, with a year-on-year change of 3720.64.
What is the net operating income of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its net operating income of Crescent Biopharma Ord Shs was -145.43M, with a year-on-year change of -347.34.
What is the net investment of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its net investment of Crescent Biopharma Ord Shs was -72.92M, with a year-on-year change of -364185.28.
What is the net financing of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its net financing of Crescent Biopharma Ord Shs was 322.98M, with a year-on-year change of 5983301.26.
What is the Earnings Per Share (EPS) of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -14.97, with a year-on-year change of 74.51.
What is the net income of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its net income was -155.94M, with a year-on-year change of -311.68.
What is the Return on Equity (ROE) of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its Return on Equity (ROE) was -152.64, with a year-on-year change of 11.90.
What is the Return on Assets (ROA) of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -124.07, with a year-on-year change of 7.62.
What is the operating profit of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2025 earnings report, its operating profit was -145.43M, with a year-on-year change of -347.34.